ArticleInternational journal of dermatology2025
Haptoglobin Genotypes in Hidradenitis Suppurativa: Haptoglobin 2-2 Genotype Is Associated With Familial Hidradenitis Suppurativa and More Flares.
Article in International journal of dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Immunohistochemical Expression of Haptoglobin in Skin Lesions of Hidradenitis Suppurativa.Life (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHaptoglobin (Hp) is an acute-phase protein and an independent marker for hidradenitis suppurativa (HS) severity. The different Hp genotypes (Hp 1-1, Hp 1-2, and Hp 2-2) differ in their antioxidant and anti-inflammatory functions. Hp genotypes have never been investigated in HS patients.
objectiveOur aim was to characterize and determine the frequency of Hp genotypes in HS patients. Additionally, the characteristics of the different Hp genotypes are analyzed for differences in personal, disease-specific, and laboratory parameters.
methodsGenomic DNA was extracted from peripheral blood leukocytes using the Maxwell RSC Blood DNA Kit. Polymerase chain reaction (PCR) products were separated and analyzed using 0.7% agarose gels for genotyping. The chi-square test, Kruskal-Wallis test, and/or post hoc analysis with the Dunn-Bonferroni test were used to determine differences between the different genotypes and HS characteristics. We compared the genotype distribution in HS with 69 randomly selected, unmatched, and healthy control patients.
resultsA total of 72 patients with HS were included in this study, including 29 women (40.3%) and 43 men (59.7%). A positive family history of HS was reported by 29.2% of patients (n = 21). Hp genotype 1-1 was present in 20.8%, Hp 1-2 in 33.3%, and Hp 2-2 in 45.8% of HS patients. The control group had a similar Hp distribution with 18.8%, 37.7%, and 43.5%, respectively. A positive family history of HS was significantly more frequent in Hp 2-2 (42.4%) compared to Hp 1-1 (6.7%) and Hp 1-2 (25%) (p = 0.035). The number of HS flares in the last 4 weeks was significantly higher in Hp 2-2 patients compared to Hp 1-2 patients (p = 0.006).
conclusionHp genotype 2-2 and the Hp2 allele were significantly more associated with familial HS than the other genotypes. In addition, HS patients with genotypes 2-2 had more frequent flare-ups than those with the different genotypes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.